Medicare Enrolled

Dr. Wonkyu Pak, M.D.

Ophthalmology · Los Angeles, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
266 S HARVARD BLVD, Los Angeles, CA 90004
2137396900
In practice since 2005 (20 years)
NPI: 1376542894 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pak? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pak

Dr. Wonkyu Pak is an ophthalmology specialist in Los Angeles, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Pak performed 3,092 Medicare services across 2,211 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pak received a total of $5,676 from 25 pharmaceutical and/or device companies across 317 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pak is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 32% volume in CA $5,676 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,092
Medicare services
Top 32% in CA for ophthalmology
2,211
Unique beneficiaries
$100
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~155 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
636 $77 $149
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
460 $106 $198
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
450 $35 $80
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
298 $55 $118
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
293 $30 $80
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
213 $97 $500
Compounded drug, not otherwise classified
A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products.
147 $73 $150
Aflibercept eye injection (Eylea) 132 $692 $1,850
Corneal topography and eye depth measurement
This procedure measures the curvature and depth of the cornea, the clear front surface of the eye.
68 $37 $150
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
67 $129 $260
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
57 $23 $50
Eyelash removal with forceps
This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area.
53 $19 $95
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
51 $9 $40
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
46 $439 $1,100
Tear duct plug insertion
A procedure to insert a small plug into the tear duct opening to help retain tears on the eye surface.
29 $154 $302
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
17 $304 $618
Nasal tear duct probing
A procedure to examine and clear the tear ducts in the nose. It helps restore normal drainage of tears from the eye.
17 $172 $359
Eye photography
Photographic imaging of the interior structures of the eye.
16 $18 $50
Visual field test, intermediate
A test that measures your side vision to check for blind spots or other vision changes.
15 $42 $80
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
15 $31 $100
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
12 $126 $220
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.5% high complexity
37.2% medium
61.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$5,676
Total received (2018-2024)
Avg $811/year across 7 years
Top 22% in CA for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
317
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,676 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$357
2023
$297
2022
$721
2021
$898
2020
$864
2019
$1,339
2018
$1,200

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$292
Oyster Point Pharma, Inc.
$43
Amgen Inc.
$22
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan, Inc.
$915
Allergan Inc.
$754
Novartis Pharmaceuticals Corporation
$637
Aerie Pharmaceuticals, Inc.
$622
Sun Pharmaceutical Industries Inc.
$513
ABBVIE INC.
$506
Shire North American Group Inc
$411
Bausch & Lomb, a division of Bausch Health US, LLC
$364
Sight Sciences, Inc.
$153
Eyevance Pharmaceuticals LLC
$153
Oyster Point Pharma, Inc.
$117
SUN PHARMACEUTICAL INDUSTRIES INC.
$82
Regeneron Healthcare Solutions, Inc.
$79
Horizon Therapeutics plc
$76
Alcon Vision LLC
$41
Optos, Inc.
$39
Carl Zeiss Meditec AG
$39
OPTOS, INC.
$34
Akorn, Inc.
$32
BioTissue Holdings, Inc.
$22
Amgen Inc.
$22
TearLab Corp
$19
Kala Pharmaceuticals, Inc.
$18
EYEVANCE PHARMACEUTICALS LLC
$16
TissueTech, Inc.
$13
Top 3 companies account for 40.6% of all-time payments
Associated products mentioned in payments ›
ALPHAGAN P · AzaSite · BESIVANCE · BROMSITE · Betimol · CEQUA · COMBIGAN · Cequa · DUREZOL · DURYSTA · ENVISTA · EYLEA · Flarex · ILEVRO · INVELTYS · LUMIGAN · Monaco · None Specified · OMNI SURGICAL SYSTEM · OMNI Surgical System · OMNI(R) SURGICAL SYSTEM (US) · OZURDEX · P200DTx · PAZEO · PROKERA · PROLENSA · Prokera · RESTASIS · RESTASIS MULTIDOSE · Rhopressa · Rocklatan · Simbrinza · TEPEZZA · TRAVATAN Z · TYRVAYA · TearCare SmartLid · TearLab Osmolarity System · Tobradex ST · VUITY · VYZULTA · XELPROS · XEN · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an ophthalmology specialist in Los Angeles?
Compare ophthalmologists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
768
Per 100K population
7.8
County median income
$87,760
Nearest hospital
SOUTHERN CALIFORNIA HOSPITAL AT HOLLYWOOD
1.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pak is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pak experienced with eye exam, established patient, focused?
Based on Medicare claims data, Dr. Pak performed 636 eye exam, established patient, focused services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pak receive payments from pharmaceutical companies?
Yes. Dr. Pak received a total of $5,676 from 25 companies across 317 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pak's costs compare to other ophthalmologists in Los Angeles?
Dr. Pak's average Medicare payment per service is $100. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →